BioMaxima S.A. (WSE:BMX)

BioMaxima Statistics

Total Valuation

BioMaxima has a market cap or net worth of PLN 55.56 million. The enterprise value is 71.43 million.

Market Cap	55.56M
Enterprise Value	71.43M

Important Dates

The next estimated earnings date is Sunday, November 30, 2025.

Earnings Date	Nov 30, 2025
Ex-Dividend Date	n/a

Share Statistics

BioMaxima has 4.19 million shares outstanding. The number of shares has decreased by -0.87% in one year.

Current Share Class	4.19M
Shares Outstanding	4.19M
Shares Change (YoY)	-0.87%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.38%
Owned by Institutions (%)	n/a
Float	2.69M

Valuation Ratios

The trailing PE ratio is 79.50.

PE Ratio	79.50
Forward PE	n/a
PS Ratio	0.97
PB Ratio	1.18
P/TBV Ratio	1.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.67, with an EV/FCF ratio of -23.30.

EV / Earnings	101.75
EV / Sales	1.25
EV / EBITDA	14.67
EV / EBIT	51.69
EV / FCF	-23.30

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.35.

Current Ratio	1.44
Quick Ratio	0.71
Debt / Equity	0.35
Debt / EBITDA	3.37
Debt / FCF	-5.35
Interest Coverage	1.23

Financial Efficiency

Return on equity (ROE) is 1.50% and return on invested capital (ROIC) is 1.41%.

Return on Equity (ROE)	1.50%
Return on Assets (ROA)	1.14%
Return on Invested Capital (ROIC)	1.41%
Return on Capital Employed (ROCE)	2.35%
Revenue Per Employee	452,746
Profits Per Employee	5,571
Employee Count	126
Asset Turnover	0.75
Inventory Turnover	2.14

Taxes

Income Tax	-235,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.12% in the last 52 weeks. The beta is 0.12, so BioMaxima's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-12.12%
50-Day Moving Average	13.18
200-Day Moving Average	13.40
Relative Strength Index (RSI)	46.70
Average Volume (20 Days)	5,099

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioMaxima had revenue of PLN 57.05 million and earned 702,000 in profits. Earnings per share was 0.17.

Revenue	57.05M
Gross Profit	27.46M
Operating Income	1.38M
Pretax Income	467,000
Net Income	702,000
EBITDA	4.59M
EBIT	1.38M
Earnings Per Share (EPS)	0.17

Balance Sheet

The company has 528,000 in cash and 16.40 million in debt, giving a net cash position of -15.87 million or -3.79 per share.

Cash & Cash Equivalents	528,000
Total Debt	16.40M
Net Cash	-15.87M
Net Cash Per Share	-3.79
Equity (Book Value)	47.17M
Book Value Per Share	11.25
Working Capital	8.49M

Cash Flow

In the last 12 months, operating cash flow was -1.09 million and capital expenditures -1.98 million, giving a free cash flow of -3.07 million.

Operating Cash Flow	-1.09M
Capital Expenditures	-1.98M
Free Cash Flow	-3.07M
FCF Per Share	-0.73

Margins

Gross margin is 48.14%, with operating and profit margins of 2.42% and 1.23%.

Gross Margin	48.14%
Operating Margin	2.42%
Pretax Margin	0.82%
Profit Margin	1.23%
EBITDA Margin	8.04%
EBIT Margin	2.42%
FCF Margin	n/a

Dividends & Yields

BioMaxima does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.87%
Shareholder Yield	0.87%
Earnings Yield	1.26%
FCF Yield	-5.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioMaxima has an Altman Z-Score of 2.67 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.67
Piotroski F-Score	5